Clinical Trial: Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Advanced Urothelial Carcinoma
Study Type: INTERVENTIONAL
Official Title: A Phase II Trial With Copanlisib Plus Avelumab as a Maintenance Therapy for Metastatic Bladder Cancer After Platinum-based Chemotherapy
Brief Summary:
Patients with metastatic bladder cancer are usually treated with chemotherapy.If their cancers do not progress after chemotherapy, they can be enrolled into this study and receive a standard-of-care immunotherapy medication named avelumab plus a study drug named copanlisib.
Read more